InvestorsHub Logo
icon url

Trend-Setter

12/21/17 3:13 PM

#5045 RE: imapro #5044

Yeah! Another to watch for is MYMX. If this microcap @.02 is able to attract Astellas Pharma, Sanofi(currently). Why not NVAX??? Although, Sanofi just acquired Protein Sciences for their cell-based VLP platform. What's NVAX's chance? A BP partnership in 2018 would be great!
icon url

the gipper

12/21/17 4:25 PM

#5046 RE: imapro #5044

Yea, I agree, and looks like the end of 2017 could get hot too!